Drug Search Results
More Filters [+]

Meprobamate

Alternative Names: meprobamate, diurnal, proquanil, amosene, equanil, meprospan, bamate, miltown, tranmep, neuramate, mepriam, equagesic, milprem-400, milprem-200, pmb 400, micrainin, pmb 200, q-gesic
Latest Update: 2024-12-18
Latest Update Note: News Article

Product Description

Meprobamate is used to treat anxiety disorders or for short-term relief of the symptoms of anxiety in adults and children 6 years of age and older. Meprobamate is in a class of medications called tranquilizers. It works by slowing activity in the brain to allow for relaxation. (Sourced from: https://medlineplus.gov/druginfo/meds/a682077.html)

Mechanisms of Action: GABA Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral,Intravenous,Intraocular

FDA Designation: None *

Approval Status: Approved

Approved Countries: Argentina | Brazil | Canada | Chile | Egypt | Ireland | Lebanon | Morocco | New Zealand | Pakistan | Portugal | South Africa | Taiwan | Thailand | Tunisia | United Kingdom | United States

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Meprobamate

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events